Genomic characterization of high-risk non-muscle invasive bladder cancer-Reference-Cited by-同舟云学术

Genomic characterization of high-risk non-muscle invasive bladder cancer

Published:2016-10-14 Issue:46 Volume:7 Page:75176-75184
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Meeks Joshua J.¹,Carneiro Benedito A.²,Pai Sachin G.²,Oberlin Daniel T.¹,Rademaker Alfred³,Fedorchak Kyle⁴,Balasubramanian Sohail⁴,Elvin Julia⁴,Beaubier Nike⁵,Giles Francis J.²

Affiliation:

1. Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

2. Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA

3. Northwestern University Department of Preventive Medicine, Chicago, IL, USA

4. Foundation Medicine Inc, Cambridge, MA, USA

5. Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biomarkers of progression in non-muscle-invasive bladder cancer — beyond conventional risk stratification;Nature Reviews Urology;2024-08-02

2. Vesical Imaging‐Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle‐invasive bladder cancer;BJU International;2023-10-16

3. Immunotherapy in urothelial cancer: current status and future directions;Expert Review of Anticancer Therapy;2023-10-04

4. A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients;BMC Medicine;2023-09-19

5. Mutation Hotspots Found in Bladder Cancer Aid Prediction of Carcinogenic Risk in Normal Urothelium;International Journal of Molecular Sciences;2023-04-25